Cancer gene therapy - JoVE Visualize

Showing results (371-380 of 2,902) with videos related to

Pageof 291

Sort By:

Cancer Gene Therapy|April 7, 2007

Lentiviral vector neutral endopeptidase gene transfer suppresses prostate cancer tumor growthA Horiguchi, R Zheng, O B Goodman, et al.

Cancer Gene Therapy|April 7, 2007

Transposon-based interferon gamma gene transfer overcomes limitations of episomal plasmid for immunogene therapy of glioblastomaA Wu, S Oh, K Ericson, et al.

Cancer Gene Therapy|April 14, 2007

Adenoviral-mediated PTEN expression radiosensitizes non-small cell lung cancer cells by suppressing DNA repair capacityG Pappas, L A Zumstein, A Munshi, et al.

Cancer Gene Therapy|May 20, 2006

Oncolytic adenoviral vector carrying the cytosine deaminase gene for melanoma gene therapyY Liu, A Deisseroth

Cancer Gene Therapy|June 3, 2006

Use of the PSA enhancer core element to modulate the expression of prostate- and non-prostate-specific basal promoters in a lentiviral vector contextS Chapel-Fernandes, F Jordier, F Lauro, et al.

Cancer Gene Therapy|June 28, 2008

ONYX-411, a conditionally replicative oncolytic adenovirus, induces cell death in anaplastic thyroid carcinoma cell lines and suppresses the growth of xenograft tumors in nude miceH V Reddi, P Madde, A J Reichert-Eberhardt, et al.

Cancer Gene Therapy|September 22, 2007

Effect of RNA oligonucleotide targeting Foxo-1 on muscle growth in normal and cancer cachexia miceC-M Liu, Z Yang, C-W Liu, et al.

Cancer Gene Therapy|February 20, 2004

Treatment of bladder carcinomas using recombinant BCG DNA vaccines and electroporative gene immunotherapyChi-Feng Lee, Sun-Yran Chang, Dar-Shih Hsieh, et al.

Cancer Gene Therapy|September 9, 2004

Death receptor 4 (DR4) efficiently kills breast cancer cells irrespective of their sensitivity to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)Irene Kazhdan, Robert A Marciniak

Cancer Gene Therapy|May 1, 2004

Gallbladder cancer treatment using adenovirus expressing the HGF/NK4 gene in a peritoneal implantation modelToshihiro Tanaka, Hideo Shimura, Takamitsu Sasaki, et al.

Pageof 291

Showing results (371-380 of 2,902) with videos related to

Sort By:

Pageof 291

Cancer Gene Therapy|April 7, 2007

Lentiviral vector neutral endopeptidase gene transfer suppresses prostate cancer tumor growthA Horiguchi, R Zheng, O B Goodman, et al.

Cancer Gene Therapy|April 7, 2007

Transposon-based interferon gamma gene transfer overcomes limitations of episomal plasmid for immunogene therapy of glioblastomaA Wu, S Oh, K Ericson, et al.

Cancer Gene Therapy|April 14, 2007

Adenoviral-mediated PTEN expression radiosensitizes non-small cell lung cancer cells by suppressing DNA repair capacityG Pappas, L A Zumstein, A Munshi, et al.

Cancer Gene Therapy|May 20, 2006

Oncolytic adenoviral vector carrying the cytosine deaminase gene for melanoma gene therapyY Liu, A Deisseroth

Cancer Gene Therapy|June 3, 2006

Use of the PSA enhancer core element to modulate the expression of prostate- and non-prostate-specific basal promoters in a lentiviral vector contextS Chapel-Fernandes, F Jordier, F Lauro, et al.

Cancer Gene Therapy|June 28, 2008

ONYX-411, a conditionally replicative oncolytic adenovirus, induces cell death in anaplastic thyroid carcinoma cell lines and suppresses the growth of xenograft tumors in nude miceH V Reddi, P Madde, A J Reichert-Eberhardt, et al.

Cancer Gene Therapy|September 22, 2007

Effect of RNA oligonucleotide targeting Foxo-1 on muscle growth in normal and cancer cachexia miceC-M Liu, Z Yang, C-W Liu, et al.

Cancer Gene Therapy|February 20, 2004

Treatment of bladder carcinomas using recombinant BCG DNA vaccines and electroporative gene immunotherapyChi-Feng Lee, Sun-Yran Chang, Dar-Shih Hsieh, et al.

Cancer Gene Therapy|September 9, 2004

Death receptor 4 (DR4) efficiently kills breast cancer cells irrespective of their sensitivity to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)Irene Kazhdan, Robert A Marciniak

Cancer Gene Therapy|May 1, 2004

Gallbladder cancer treatment using adenovirus expressing the HGF/NK4 gene in a peritoneal implantation modelToshihiro Tanaka, Hideo Shimura, Takamitsu Sasaki, et al.

Pageof 291